Hamnvik LHD, Eide-Olsen S, Fosseng A, Schjesvold FH(2024) Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021 Clin Lymphoma Myeloma Leuk(in press) DOI 10.1016/j.clml.2024.07.015, PubMed 39191633
Abdollahi P, Norseth HM, Schjesvold F(2024) Advances and challenges in anti-cancer vaccines for multiple myeloma Front Immunol, 15, 1411352 DOI 10.3389/fimmu.2024.1411352, PubMed 39161773
Pawlyn C, Schjesvold FH, Cairns DA, Wei LJ, Davies F, Nadeem O, Abdulhaq H, Mateos MV, Laubach J, Weisel K, Ludwig H, Rajkumar SV, Sonneveld P, Jackson G, Morgan G, Richardson PG(2024) Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm Blood Cancer J, 14(1), 134 DOI 10.1038/s41408-024-01109-4, PubMed 39134544